Neurogen Technologies

UEI: V4K5KN6AAK19 • CAGE: 7NNS6

Overview

Awardee Type

Parent

Federal Capability Statement

The NeuroGen Technologies Inc. Lab capitalizes on advances in biotechnology, neuroscience, and the social sciences to develop the intellectual property and proprietary information needed to generate products for government and commercial clients in the biomedical and personnel-security sectors. Our research lab in Los Angeles, California includes data collection facilities with cutting-edge functional near infrared spectroscopy (fNIRS) brain-imaging and psychophysiology capabilities, and the lab is actively involved in collaborations with the University of California at Los Angeles (UCLA) and other universities. Current topics of interest include development of more effective treatments for Posttraumatic Stress Disorder (PTSD) and improved screening and prognostic indicators for traumatic brain injury (TBI)/concussions as well as tools for predicting persuasion and other effects of social messaging and enhanced mobile functional brain-imaging technologies.

Keywords

Research and Development in the Physical, Engineering

Website

https://www.neurogentech.com

Headquarters

Malibu, CA
United States

Most Recent Award

May 23, 2022

Calculating

Federal contract and grant recipient NEUROGEN TECHNOLOGIES INC (UEI V4K5KN6AAK19, CAGE 7NNS6) is headquartered in Malibu CA. Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). The corporation was founded in December 2015 and federally registered in July 2016.

Federal Award Analysis